Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Product Infusion Questions: 1 - 45

Cell product ID

Yes No

1

Cell product ID:2

Batch number

Yes No

3

Batch number:4

Lot number

Yes No

5

Lot number:6

Date of this product infusion:7 __ __ __ __ - __ __- __ __

Was the entire volume of product infused?

Yes No

8

Specify what happened to the reserved portion9

Discarded

Cryopreserved for future use

Other fate

Specify other fate:10

Specify the route of product infusion11

Intravenous

Intramedullary

Intraperitoneal

Intra arterial

Intramuscular

Intrathecal

Intraorgan

Locally in the tissue

Other route of infusion

Specify other route of infusion:12

Specify the site of intraorgan administration of cells

Bone Heart Liver Pancreas Kidney Brain Lung Other site

13

Specify other site:14

Recipient weight used for this infusion:15 pounds kilograms

Recipient height used for this infusion:16 inches centimeters

Total number of cells administered

Known Unknown

17

Total number of cells:18 x 10

Lymphocytes (unselected) administered

Yes No

19

Total number of cells:20 x 10

CD4+ lymphocytes administered

Yes No

21

Total number of cells:22 x 10

CD8+ lymphocytes administered

Yes No

23

Total number of cells:24 x 10

Natural killer cells (NK cells) administered

Yes No

25

Total number of cells:26 x 10

Dendritic cells / tumor cell hybridomas administered

Yes No

27

Total number of cells:28 x 10

Mesenchymal stromal stem cells (MSCs) administered

Yes No

29

Total number of cells:30 x 10

Unspecified mononuclear cells administered

Yes No

31

Total number of cells:32 x 10

Endothelial progenitor cells administered

Yes No

33

Total number of cells:34 x 10

Human umbilical cord perivascular (HUCPV) cells administered

Yes No

35

Total number of cells:36 x 10

Cardiac progenitor cells administered

Yes No

37

Total number of cells:38 x 10

Islet cells administered

Yes No

39

Total number of cells:40 x 10

Oligodendrocytes administered

Yes No

41

Total number of cells:42 x 10

Other cell type administered

Yes No

43

Specify other cell type:44

Total number of cells:45 x 10

Concomitant Therapy Questions: 46 - 49

Did the recipient receive concomitant therapy?

Yes No

46

Specify drugs (check all that apply)

Atezolizumab (Tecentriq)

Avelumab (Bavencio)

Durvalumab

GM-CSF

IL-2

IL-15

Ipilimumab (Yervoy)

Lenalidomide (Revlimid)

Nivolumab (Opdiva)

Pembrolizumab (Keytruda)

Pomalidomide

Other

47

Specify other drug:48

Specify time point

Simultaneous Post cell therapy Unknown

49

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

Specify any identifiers associated with this cell product:

Cell doses

Report the total number of cells (not cells per kilogram) contained in the product administered, not corrected for viability

Center: CRID: 

Form 4006 R3.0: Cellular Therapy Infusion

CIBMTR Form 4006 revision 3.0 last updated Monday, January 29, 2018
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 1 / 2



Key Fields

Sequence Number:

Date Received: __ __ __ __ - __ __- __ __

CIBMTR Center Number:

CIBMTR Research ID:

Event date: __ __ __ __ - __ __- __ __

Product Infusion Questions: 1 - 45

Cell product ID

Yes No

1

Cell product ID:2

Batch number

Yes No

3

Batch number:4

Lot number

Yes No

5

Lot number:6

Date of this product infusion:7 __ __ __ __ - __ __- __ __

Was the entire volume of product infused?

Yes No

8

Specify what happened to the reserved portion9

Discarded

Cryopreserved for future use

Other fate

Specify other fate:10

Specify the route of product infusion11

Intravenous

Intramedullary

Intraperitoneal

Intra arterial

Intramuscular

Intrathecal

Intraorgan

Locally in the tissue

Other route of infusion

Specify other route of infusion:12

Specify the site of intraorgan administration of cells

Bone Heart Liver Pancreas Kidney Brain Lung Other site

13

Specify other site:14

Recipient weight used for this infusion:15 pounds kilograms

Recipient height used for this infusion:16 inches centimeters

Total number of cells administered

Known Unknown

17

Total number of cells:18 x 10

Lymphocytes (unselected) administered

Yes No

19

Total number of cells:20 x 10

CD4+ lymphocytes administered

Yes No

21

Total number of cells:22 x 10

CD8+ lymphocytes administered

Yes No

23

Total number of cells:24 x 10

Natural killer cells (NK cells) administered

Yes No

25

Total number of cells:26 x 10

Dendritic cells / tumor cell hybridomas administered

Yes No

27

Total number of cells:28 x 10

Mesenchymal stromal stem cells (MSCs) administered

Yes No

29

Total number of cells:30 x 10

Unspecified mononuclear cells administered

Yes No

31

Total number of cells:32 x 10

Endothelial progenitor cells administered

Yes No

33

Total number of cells:34 x 10

Human umbilical cord perivascular (HUCPV) cells administered

Yes No

35

Total number of cells:36 x 10

Cardiac progenitor cells administered

Yes No

37

Total number of cells:38 x 10

Islet cells administered

Yes No

39

Total number of cells:40 x 10

Oligodendrocytes administered

Yes No

41

Total number of cells:42 x 10

Other cell type administered

Yes No

43

Specify other cell type:44

Total number of cells:45 x 10

Concomitant Therapy Questions: 46 - 49

Did the recipient receive concomitant therapy?

Yes No

46

Specify drugs (check all that apply)

Atezolizumab (Tecentriq)

Avelumab (Bavencio)

Durvalumab

GM-CSF

IL-2

IL-15

Ipilimumab (Yervoy)

Lenalidomide (Revlimid)

Nivolumab (Opdiva)

Pembrolizumab (Keytruda)

Pomalidomide

Other

47

Specify other drug:48

Specify time point

Simultaneous Post cell therapy Unknown

49

First Name:

Last Name:

E-mail address:

Date: __ __ __ __ - __ __- __ __

Specify any identifiers associated with this cell product:

Cell doses

Report the total number of cells (not cells per kilogram) contained in the product administered, not corrected for viability

Center: CRID: 

Form 4006 R3.0: Cellular Therapy Infusion

CIBMTR Form 4006 revision 3.0 last updated Monday, January 29, 2018
Copyright(c) 2012 National Marrow Donor Program and

The Medical College of Wisconsin, Inc. All rights reserved. Page 2 / 2